ZA200100320B - Compounds, compositions and methods for stimulating neuronal growth and elongation. - Google Patents

Compounds, compositions and methods for stimulating neuronal growth and elongation. Download PDF

Info

Publication number
ZA200100320B
ZA200100320B ZA200100320A ZA200100320A ZA200100320B ZA 200100320 B ZA200100320 B ZA 200100320B ZA 200100320 A ZA200100320 A ZA 200100320A ZA 200100320 A ZA200100320 A ZA 200100320A ZA 200100320 B ZA200100320 B ZA 200100320B
Authority
ZA
South Africa
Prior art keywords
group
alkyl
compound
substituted
unsubstituted
Prior art date
Application number
ZA200100320A
Other languages
English (en)
Inventor
Susumu Katoh
Hiroshi Kawakami
Hiroko Tada
Vincent Kalish
Jesus Ernesto Villafranca
Maria Angelica Linton
John Howard Tatlock
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of ZA200100320B publication Critical patent/ZA200100320B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA200100320A 1998-07-17 2001-01-11 Compounds, compositions and methods for stimulating neuronal growth and elongation. ZA200100320B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9329998P 1998-07-17 1998-07-17
US13288499P 1999-05-06 1999-05-06

Publications (1)

Publication Number Publication Date
ZA200100320B true ZA200100320B (en) 2002-07-11

Family

ID=26787372

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200100320A ZA200100320B (en) 1998-07-17 2001-01-11 Compounds, compositions and methods for stimulating neuronal growth and elongation.

Country Status (35)

Country Link
US (1) US6630472B1 (enExample)
EP (1) EP1098897B1 (enExample)
JP (1) JP2002520413A (enExample)
KR (1) KR20010071920A (enExample)
CN (1) CN1318067A (enExample)
AP (1) AP2001002052A0 (enExample)
AT (1) ATE268772T1 (enExample)
AU (1) AU756912B2 (enExample)
BG (1) BG105268A (enExample)
BR (1) BR9912423A (enExample)
CA (1) CA2337377A1 (enExample)
DE (1) DE69917907T2 (enExample)
DK (1) DK1098897T3 (enExample)
EA (1) EA200100149A1 (enExample)
EE (1) EE200100032A (enExample)
ES (1) ES2226409T3 (enExample)
GE (1) GEP20043368B (enExample)
HR (1) HRP20010118A2 (enExample)
HU (1) HUP0200637A3 (enExample)
ID (1) ID27428A (enExample)
IL (1) IL140676A0 (enExample)
IS (1) IS5805A (enExample)
LT (1) LT4850B (enExample)
LV (1) LV12665B (enExample)
NO (1) NO20010191L (enExample)
NZ (1) NZ509211A (enExample)
OA (1) OA11581A (enExample)
PL (1) PL345598A1 (enExample)
PT (1) PT1098897E (enExample)
SI (1) SI20638A (enExample)
SK (1) SK462001A3 (enExample)
TR (1) TR200100122T2 (enExample)
WO (1) WO2000004020A1 (enExample)
YU (1) YU2901A (enExample)
ZA (1) ZA200100320B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818643B1 (en) * 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
MXPA03010255A (es) * 2001-05-10 2005-03-07 Agouron Pharma Ligandos heterobiciclicos de proteinas de union a fk-506.
EP2899192A1 (en) * 2014-01-24 2015-07-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
WO2015110271A1 (en) * 2014-01-24 2015-07-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5109112A (en) 1989-01-19 1992-04-28 Merck & Co., Inc. FK-506 cytosolic binding protein
US5196352A (en) 1989-01-19 1993-03-23 Merck & Co., Inc. New FK-506 cytosolic binding protein
US5192773A (en) 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
US5256656A (en) * 1990-07-31 1993-10-26 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives
CA2068062A1 (en) 1991-05-07 1992-11-08 Stephen A. Parent Yeast mutants
US5362629A (en) 1991-08-05 1994-11-08 President And Fellows Of Harvard College Detection of immunosuppressants
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
DE4219973A1 (de) 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5318895A (en) 1992-10-05 1994-06-07 Merck & Co., Inc. Aspergillus niger mutants
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
US5612350A (en) 1993-11-30 1997-03-18 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements
DE4341402A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5457182A (en) 1994-02-15 1995-10-10 Merck & Co., Inc. FK-506 cytosolic binding protein, FKBP12.6
US5622866A (en) 1994-06-23 1997-04-22 Merck & Co., Inc. Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5786378A (en) 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5840736A (en) 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5811434A (en) 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
PA8442401A1 (es) 1996-12-09 2000-05-24 Guilford Pharm Inc Inhibidores polipropilos de ciclofilina
US5874449A (en) 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US5935989A (en) 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
US5721256A (en) 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
ZA98825B (en) 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones

Also Published As

Publication number Publication date
LV12665B (lv) 2001-11-20
DE69917907D1 (de) 2004-07-15
BG105268A (en) 2001-11-30
GEP20043368B (en) 2004-04-13
SK462001A3 (en) 2002-02-05
EP1098897B1 (en) 2004-06-09
YU2901A (sh) 2004-05-12
LT4850B (lt) 2001-10-25
IL140676A0 (en) 2002-02-10
LV12665A (en) 2001-05-20
DE69917907T2 (de) 2005-06-30
US6630472B1 (en) 2003-10-07
HRP20010118A2 (en) 2002-02-28
TR200100122T2 (tr) 2001-08-21
LT2001012A (en) 2001-07-25
ES2226409T3 (es) 2005-03-16
AU4996399A (en) 2000-02-07
PL345598A1 (en) 2001-12-17
NO20010191D0 (no) 2001-01-12
HUP0200637A3 (en) 2003-05-28
NZ509211A (en) 2002-10-25
CA2337377A1 (en) 2000-01-27
EA200100149A1 (ru) 2001-08-27
EP1098897A1 (en) 2001-05-16
DK1098897T3 (da) 2004-10-18
CN1318067A (zh) 2001-10-17
ATE268772T1 (de) 2004-06-15
AP2001002052A0 (en) 2001-03-31
KR20010071920A (ko) 2001-07-31
HUP0200637A2 (en) 2002-08-28
IS5805A (is) 2001-01-12
NO20010191L (no) 2001-03-16
BR9912423A (pt) 2001-06-05
EE200100032A (et) 2002-06-17
JP2002520413A (ja) 2002-07-09
SI20638A (sl) 2002-02-28
PT1098897E (pt) 2004-10-29
AU756912B2 (en) 2003-01-23
ID27428A (id) 2001-04-05
OA11581A (en) 2004-07-23
WO2000004020A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
RU2041211C1 (ru) Конденсированные 5-членные гетероциклы или их соли, проявляющие активность по торможению агрегации
HU221293B1 (en) Substituted pyridyl dihydroxyheptenoic acid salt and pharmaceutical compositions comprising same, process for producing them and the intermediates
US5670534A (en) Distamycin a derivatives as anti-malarial agents
EA027828B1 (ru) Противовирусные соединения
JPS5976086A (ja) プテリジン化合物
HUT71353A (en) 4-[4'-piperidinyl or 3'pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof
HU210822A9 (en) Pyrimidine-4,6-dicarboxylic acid diamides, processes for the use thereof, and pharmaceuticals based on these compounds
EP1460077A1 (en) Novel pyrazolopyrimidones and their use as PDE inhibitors
US10781172B2 (en) Catalysts and methods for enantioselective conjugate additions of amines to unsaturated electrophiles
US6365585B1 (en) Phosphodiesterase IV-inhibiting diazepinoindoles
HUP0100832A2 (hu) Kinoxalin- és kinolin-karbonsavamid-származékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
Kassem et al. New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling
US4985433A (en) 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
UA81640C2 (ru) Противомикобактериальные соединения, способ их получения, фармацевтическая композиция на их основе
Antonucci et al. Characterization of the antiviral activity of highly substituted pyrroles: a novel class of non-nucleoside HIV-1 reverse transcriptase inhibitor
WO2004106299A8 (en) Substituted pyrrole derivatives and their use as hmg-co inhibitors
JP2009527538A (ja) Ｃｄ８０アンタゴニストの塩
Walker et al. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl) isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors
Pettit et al. Chiral modifications of dolastatin 10: the potent cytostatic peptide (19aR)-isodolastatin 10
WO2005053702A2 (en) Anti-inflammatory agents
JP5220601B2 (ja) コリスマイシンおよびその誘導体の、酸化ストレス抑制剤としての使用
JP2007537242A (ja) 抗マイコバクテリア医薬組成物
US6399607B1 (en) Aminomethylene amide analogs of pyrazinamide with intracellular antimycobacterial activity against pyrazinamide-resistant mycobacteria combined with a rifamycin
US5714500A (en) 2-phenyl- and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties
Tsui et al. Synthesis and study of a spin-labeled cyclophosphamide analog 3-(1-oxy-2, 2, 6, 6-tetramethyl-4-piperidinyl) cyclophosphamide